Our data strongly suggest overexpression of VEGF-A in patients with metabolic syndrome, hyperglycemia, hypertriglyceridemia and hypertension, but not obesity and high LDL. This evidence concerns the gene VEGFA and obesity due to melanocortin 4 receptor deficiency.